FMTX NASDAQ
Forma Therapeutics Holdings, Inc.
1W: +0.3%
1M: +0.4%
3M: +126.9%
1Y: +11.2%
$20.01
Last traded 2022-10-13 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$561M
-17.6% ▼
3Y CAGR: +28.7%
Total Liabilities
$63M
+91.6% ▲
3Y CAGR: -36.6%
Shareholders Equity
$498M
-23.1% ▼
3Y CAGR: +204.9%
Cash & Investments
$464M
-26.7% ▼
3Y CAGR: +45.0%
Total Debt
$33M
+0.0% ▲
Net Debt
-$45M
+84.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
| — Assets — | ||||
| Cash | $83M | $173M | $283M | $77M |
| Short-Term Investments | $69M | $0 | $350M | $387M |
| Cash & ST Investments | $152M | $173M | $633M | $464M |
| Net Receivables | $98M | $875K | $15M | $13M |
| Inventory | $0 | $0 | $0 | $0 |
| Other Current Assets | $5M | $3M | $6M | $9M |
| Total Current Assets | $255M | $177M | $654M | $486M |
| Property, Plant & Equip. | $7M | $5M | $2M | $36M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $13M | $26M |
| Other Non-Current Assets | $621K | $620K | $12M | $13M |
| Total Non-Current Assets | $8M | $6M | $27M | $75M |
| Total Assets | $263M | $183M | $681M | $561M |
| — Liabilities — | ||||
| Accounts Payable | $6M | $4M | $4M | $4M |
| Short-Term Debt | $4M | $0 | $0 | $5M |
| Deferred Revenue | $203M | $1M | $0 | $0 |
| Other Current Liabilities | $21M | $20M | $27M | $26M |
| Total Current Liabilities | $234M | $25M | $32M | $35M |
| Long-Term Debt | $0 | $0 | $0 | $28M |
| Other Non-Current Liab. | $3M | $3M | $1M | $0 |
| Total Non-Current Liabilities | $12M | $3M | $1M | $28M |
| Total Liabilities | $246M | $27M | $33M | $63M |
| — Equity — | ||||
| Common Stock | $229K | $24K | $47K | $47K |
| Retained Earnings | -$55M | $17M | -$57M | -$230M |
| Accumulated OCI | -$17M | -$20M | -$681M | $0 |
| Total Stockholders Equity | $18M | $156M | $648M | $498M |
| Total Liabilities & Equity | $263M | $183M | $681M | $561M |
| — Key Metrics — | ||||
| Total Debt | $0 | $0 | $0 | $33M |
| Net Debt | -$83M | -$173M | -$283M | -$45M |
| Total Investments | $69M | $0 | $363M | $413M |